CHARM Therapeutics Funding: $80M Raised, Series B (2025)
CHARM Therapeutics is a Biotech company based in Cambridge, MA. It has raised $80M in total funding. Latest round: Series B.
CHARM Therapeutics funding overview
CHARM Therapeutics is a Biotech company based in Cambridge, MA. CHARM Therapeutics has raised $80M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in September 2025. The round record for CHARM Therapeutics runs through 2025; nothing later has been disclosed. Investors on record include New Enterprise Associates, SR One, OrbiMed, F-Prime, NVIDIA, Khosla Ventures. 6 distinct backers are named across the disclosed rounds.
CHARM Therapeutics at a glance
Total raised
$80M
Latest round
Series B
Latest round date
September 2025
Industry
Biotech
Headquarters
Cambridge, MA
Notable investors
New Enterprise Associates, SR One, OrbiMed, F-Prime, NVIDIA, Khosla Ventures
Frequently asked about CHARM Therapeutics funding
How much has CHARM Therapeutics raised?
CHARM Therapeutics has raised $80M in total disclosed funding across the rounds on record.
Who has invested in CHARM Therapeutics?
New Enterprise Associates, SR One, OrbiMed, F-Prime, NVIDIA, Khosla Ventures are named among the investors backing CHARM Therapeutics.
What was the latest CHARM Therapeutics funding round?
The most recent disclosed round is a Series B, announced in September 2025.
Where is CHARM Therapeutics based?
CHARM Therapeutics is based in Cambridge, MA.
What sector does CHARM Therapeutics operate in?
CHARM Therapeutics is tracked under Biotech from Cambridge, MA, with $80M in disclosed funding.
When did CHARM Therapeutics last raise?
The last disclosed CHARM Therapeutics round closed in September 2025 at Series B.
CHARM Therapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related Biotech companies in Cambridge below to benchmark round size and investor mix.
